The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 19, 2026
Snapshot (as of Oct 19, 2026): STERIS plc (STE) pays a $2.52 annual dividend ($0.69 quarterly), yielding 1.16% at $222.66/share. Next ex-dividend date 2026-09-04. 15 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.16%
Annual Dividend: $2.52 per share
Payout Ratio: 30.8%
Ex-Dividend Date: 2026-09-04
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 22
STERIS plc dividend reflects a company built around infection prevention: sterilizers, surgical tables, endoscope reprocessing systems, and outsourced sterile processing for hospitals and medical device manufacturers. STE currently yields 1.2%, with trailing twelve-month payments of $2.52 per share paid quarterly. The next ex-dividend date is September 4, 2026. A beta of 0.925 puts this stock close to market-average volatility, which suits growth-and-income investors who want dividend expansion without sharp price swings.
STERIS plc pays out 30.8% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial room to sustain and grow the dividend, supported by a business model built on recurring demand: hospitals and pharmaceutical manufacturers need sterilization and infection prevention services continuously, not cyclically. STERIS plc dividend safety benefits from that recurring revenue base, though capital-intensive equipment segments and potential healthcare spending pressures represent the most data-supported risk to future payout capacity.
STERIS plc dividend history shows a CAGR of 9.9% per year from 2011 to 2025. Per-share payments grew from $0.64 to $2.40 over that window (2026 data is partial and excluded from the CAGR calculation). The smallest annual increase in the window was 7.8% in 2021, which means even in the weakest year on record, STE still delivered a raise that outpaced most inflation readings. Fifteen consecutive years of increases reinforce that this is a company that treats dividend growth as a priority, not an afterthought.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +10.1% | $1.80 (2022) | $2.40 (2025) |
| 5-Year | +9.3% | $1.54 (2020) | $2.40 (2025) |
| 10-Year | +9.6% | $0.96 (2015) | $2.40 (2025) |
STE fits growth-and-income investors who care more about how fast the dividend grows than how much it yields today. The yield is low (below 2%) at 1.2%, and that is the central trade-off: the current yield sits above the 5-year average of 0.91%, so income is slightly better than it has historically been, but it still will not satisfy investors who need immediate cash flow. What STE offers instead is a 9.9% annual growth rate over 14 years and a 30.8% payout ratio that leaves room for more. The business, centered on infection prevention products and services for hospitals and pharmaceutical manufacturers, generates the kind of recurring demand that supports sustained dividend growth. Investors get compounding dividend growth; they accept a low starting yield.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-04 | $0.6900 |
| 2026-06-08 | $0.6300 |
| 2026-02-17 | $0.6300 |
| 2025-11-18 | $0.6300 |
| 2025-09-04 | $0.6300 |
| 2025-06-10 | $0.5700 |
| 2025-02-20 | $0.5700 |
| 2024-11-19 | $0.5700 |
| 2024-09-05 | $0.5700 |
| 2024-06-12 | $0.5200 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.9500 |
| 2025 | $2.4000 |
| 2024 | $2.1800 |
| 2023 | $1.9800 |
| 2022 | $1.8000 |
Project income from STE with the STE dividend calculator or track your full portfolio with the dividend tracker.